Lawrence M. Blatt, Ph.D. 13D and 13G filings for Aligos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-12 8:30 pm Purchase |
2025-03-10 | 13D | Aligos Therapeutics, Inc. ALGS |
Lawrence M. Blatt, Ph.D. | 175,509 3.200% |
175,509 (New Position) |
Filing |